# A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)

> **NCT03452488** · PHASE2 · COMPLETED · sponsor: **Biophytis** · enrollment: 233 (actual)

## Conditions studied

- Sarcopenia
- Gait Disorders in Old Age
- Muscle Weakness

## Interventions

- **DRUG:** BIO101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03452488
- **Lead sponsor:** Biophytis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-07
- **Primary completion:** 2020-04-26
- **Final completion:** 2020-04-26
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03452488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03452488, "A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03452488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*